Image de couverture de livre

Moving the Needle for Oncology Dose Optimization: A Call for Action

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Karthik Venkatakrishnan, Priya Jayachandran, Shirley K. Seo, Piet H. van der Graaf, John A. Wagner, Neeraj Gupta
Format:	Artículo Open Access
Publié:	Wiley 2024
Sujets:	Clinical Pharmacology & Therapeutics
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Getting the Dosage Right: A Vital Role for Clinical Pharmacology in the Era of Precision Medicine
par: Iris K. Minichmayr, et autres
Publié: (2024)

Innovations in Clinical Pharmacology: Shaping the Future of Evidence Generation in Research, Development, and Utilization of Medicines
par: Karthik Venkatakrishnan, et autres
Publié: (2025)

Liberty on Odaiba, Against the Silhouette of Tokyo Bay: Inspirations for Moving Hypothesis‐Generating Research to Patient‐Centered Therapeutics
par: Karthik Venkatakrishnan
Publié: (2026)

Interchanging Biosimilars Using Proteomics
par: Piet H. van der Graaf, et autres
Publié: (2025)

Progress in Clinical Pharmacology in China: An Ongoing Evolution
par: Liang Zhao, et autres
Publié: (2025)

Weaning off ThoroughQTStudies
par: Mai Mehanna, et autres
Publié: (2024)

Dose Optimization in Oncology Drug Development: An International Consortium for Innovation and Quality in Pharmaceutical Development White Paper
par: Divya Samineni, et autres
Publié: (2024)

History and Evolution of Innovations in Clinical Pharmacology
par: Lawrence J. Lesko, et autres
Publié: (2025)

Best Practices for Pharmacokinetic Studies of New Chemical Entities
par: Ya‐Feng Wen, et autres
Publié: (2024)

Reflections on Model‐Informed Drug Development
par: Lawrence J. Lesko, et autres
Publié: (2024)

Progress in Clinical Pharmacology in China: A Randomized Controlled Study to Advance Genotype‐Guided Precision Medicine
par: Liang Zhao, et autres
Publié: (2024)

Model‐Based Patient Selection and Dosing Strategies for HRAS and PIK3CA Dysregulated HNSCC : A QSP Model for Alpelisib and Tipifarnib Combination
par: Jaehee Shim, et autres
Publié: (2026)

Artificial Intelligence/Machine Learning: The New Frontier of Clinical Pharmacology and Precision Medicine
par: Qi Liu, et autres
Publié: (2024)

Optimizing Brentuximab Vedotin Dosing in Pediatric Patients with Advanced Hodgkin Lymphoma: A Population Pharmacokinetic and Exposure‐Response Analysis
par: Xiaofei Zhou, et autres
Publié: (2025)

Dose Optimization in Oncology Drug Development: Risk Factors for Postmarketing Requirements and Commitments
par: Hiroe Kitagaki, et autres
Publié: (2025)

The Potential of Disease Progression Modeling to Advance Clinical Development and Decision Making
par: Mary Summer Starling, et autres
Publié: (2024)

Dosing Strategies and Quantitative Clinical Pharmacology for Bispecific T‐Cell Engagers Development in Oncology
par: Mohamed Elmeliegy, et autres
Publié: (2024)

Quantitative Systems Pharmacology‐Based Digital Twins Approach Supplements Clinical Trial Data for Enzyme Replacement Therapies in Pompe Disease
par: Chanchala Kaddi, et autres
Publié: (2024)

Bridging the Gap: Integrating Quantitative Systems Pharmacology and Pharmacometrics in Drug Development
par: Georgi I. Kapitanov, et autres
Publié: (2025)

From Global Impact to Pharmacoequity: A Call to Action for Clinical Pharmacology
par: Karen Rowland Yeo, et autres
Publié: (2026)

Therapeutic Drug Monitoring of Oral Oncology Drugs: Finding the Right Nails
par: Niels A. D. Guchelaar, et autres
Publié: (2024)

Seasons of Growth: Reflections on the CPT Editor‐in‐Training Program
par: Matthijs W. van Hoogdalem, et autres
Publié: (2025)

Model‐Informed Selection of the Recommended Phase 2 Dosage for Anti‐TIGIT Immunotherapy Leveraging co‐Expressed PD‐1 Inhibitor Target Engagement
par: Irina Kareva, et autres
Publié: (2025)

A Translational Model‐Based Meta‐Analysis to Predict Tremor Incidence Associated with Serotonin Reuptake Transporter Inhibition
par: Sheetal K. Panday, et autres
Publié: (2025)

Dosage Optimization: A Regulatory Perspective for Developing Oncology Drugs
par: Atiqur Rahman, et autres
Publié: (2024)

Clinical Safety of Extended Interval Dosing of Nivolumab in Patients with Melanoma
par: Ruben Malmberg, et autres
Publié: (2025)

Emulating Comparative Oncology Trials With Real‐World Evidence Studies ( ENCORE ): Process Development and Methodological Considerations for Oncology Real‐World Data
par: Janick Weberpals, et autres
Publié: (2026)

Folinic Acid Prophylaxis and Dose Adjustments Enable Safe Treatment with Pemetrexed in Patients with Renal Impairment
par: Nikki de Rouw, et autres
Publié: (2025)

Dose Optimization Informed by PBPK Modeling: State‐of‐the Art and Future
par: Karen Rowland Yeo, et autres
Publié: (2024)

Using Quantitative Approaches to Optimize Dosages for New Combinations and Subsequent Indications for Oncology Drugs
par: Wei Gao, et autres
Publié: (2025)

The Drug Titration Paradox Updated and Reinterpreted: With Perfect Titration, Dose and Effect Will Be Uncorrelated
par: Elie Sarraf, et autres
Publié: (2025)

Optimizing Body Size‐Based Dosing Approaches for Antibody–Drug Conjugates
par: Andrew B. SyBing, et autres
Publié: (2025)

Advancing Pharmacoequity Globally: Reflections from the ASCPT Development, Regulatory, and Outcomes Network
par: Priya Jayachandran, et autres
Publié: (2026)

Optimal Drug, Optimal Dose, or Both in the Pharmacological Treatment of Neonatal Opioid Withdrawal Syndrome?
par: Walter K. Kraft
Publié: (2025)

Implementing Pre‐Emptive Pharmacogenetics: Impact of Early Pharmacogenetic Screening in a Pediatric Oncology Cohort of 1,151 Subjects
par: Emma C. Bernsen, et autres
Publié: (2025)

Model‐Informed Precision Dosing of Busulfan for Children and Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Critical Evaluation of Current PK Models and Dose Recommendations
par: Rashudy F. Mahomedradja, et autres
Publié: (2025)

Dose Selection for DuoBody®‐CD40x4‐1BB (GEN1042/BNT312) Using a mPBPK/RO Model Leveraging Preclinical and Clinical Data
par: Gaurav Bajaj, et autres
Publié: (2025)

Correction to “Optimizing Hydroxychloroquine Dosing for Patients With COVID‐19: An Integrative Modeling Approach for Effective Drug Repurposing”
Publié: (2025)

Evolving Recommendations for Patient Populations Among Oncology Medicines: A Quantitative and Qualitative Analysis
par: Milou A. Hogervorst, et autres
Publié: (2025)

Piperacillin Population Pharmacokinetics in Plasma and Peritoneal Fluid and Dosing Optimization in Children Undergoing Liver Transplant: An Optimome Study
par: Noémie de Cacqueray, et autres
Publié: (2026)